首页 | 本学科首页   官方微博 | 高级检索  
检索        

浅析我国《药品管理法》对假劣药的界定
引用本文:赵健,邵蓉.浅析我国《药品管理法》对假劣药的界定[J].药学进展,2004,28(8):379-381.
作者姓名:赵健  邵蓉
作者单位:中国药科大学,江苏,南京,210009
摘    要:修订后的《药品管理法》的一个重要特点就是扩大了假劣药定义的外延并加大了对制售假劣药品的处罚力度,而要如实恰当地对违法行为量刑处罚,就必须对假劣药品赋以明确概念。因此,界定假劣药品的意义十分重要和必要。以美国对不合格药品的划分为对照,探究我国对假劣药的界定及存在问题,并提出一些建议。

关 键 词:假药  劣药  界定
文章编号:1001-5094(2004)08-0379-03
修稿时间:2004年5月1日

Sample Interpretation of Definition of Adulterated Drug and Misbranded Drug in Drug Management Law
ZHAO Jian,SHAO Rong.Sample Interpretation of Definition of Adulterated Drug and Misbranded Drug in Drug Management Law[J].Progress in Pharmaceutical Sciences,2004,28(8):379-381.
Authors:ZHAO Jian  SHAO Rong
Abstract:A significant characteristic of the Revised Drug Administration Law is that it extends the definition of adulterated drug and misbranded drug, and increases the punishment of manufacturer and seller of them. Only by making a clear definition of adulterated drug and misbranded drug can we deal with illegal activities accurately and properly. Therefore, it is particularly important and necessary to define adulterated drug and misbranded drug. This paper compares the definition of adulterated drug and misbranded drug of China with those of U.S.A., probes into the problems of the definition in the Drug Administration Law, and makes some suggestions.
Keywords:Adulterated drug  Misbranded drug  Definition  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号